08.01.2014 Views

DM Full Guideline (2010) - VA/DoD Clinical Practice Guidelines Home

DM Full Guideline (2010) - VA/DoD Clinical Practice Guidelines Home

DM Full Guideline (2010) - VA/DoD Clinical Practice Guidelines Home

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Version 4.0<br />

<strong>VA</strong>/<strong>DoD</strong> <strong>Clinical</strong> <strong>Practice</strong> <strong>Guideline</strong><br />

for the Management of Diabetes Mellitus<br />

Rickheim PL, Weaver TW, Flader JL et al. Assessment of group versus individual diabetes education: a<br />

randomized study. Diabetes Care 2002; 25(2): 269-74.<br />

Riddle MC, Rosenstock J, Gerich J. The Treat-to-Target Trial: randomized addition of glargine or human NPH<br />

insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003; 26(11): 3080-6.<br />

Rith-Najarian SJ, Stolusky T, Gohdes <strong>DM</strong>. Identifying diabetic patients at high risk for lower-extremity<br />

amputation in a primary health care setting. A prospective evaluation of simple screening criteria. Diabetes<br />

Care 1992; 15(10): 1386-9.<br />

Roberts VL, Stewart J, Issa M et al. Triple therapy with glimepiride in patients with type 2 diabetes mellitus<br />

inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, doubleblind,<br />

placebo-controlled, parallel-group study. Clin Ther 2005; 27(10): 1535-47.<br />

Rosenstock J, Aguilar-Salinas C, Klein E et al. Effect of saxagliptin monotherapy in treatment-naive patients with<br />

type 2 diabetes. Curr Med Res Opin 2009; 25(10): 2401-11.<br />

Rosenstock J, Brazg R, Andryuk PJ et al. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin<br />

added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter,<br />

randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther 2006a; 28(10): 1556-68.<br />

Rosenstock J, Sugimoto D, Strange P et al. Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone<br />

added to combination therapy of sulfonylurea plus metformin in insulin-naive patients. Diabetes Care<br />

2006b; 29(3): 554-9.<br />

Rubin DJ, Moshang J, Jabbour SA. Diabetes knowledge: are resident physicians and nurses adequately prepared to<br />

manage diabetes? Endocr Pract 2007; 13(1): 17-21.<br />

Rubin RJ, Dietrich KA, Hawk AD. <strong>Clinical</strong> and economic impact of implementing a comprehensive diabetes<br />

management program in managed care. J Clin Endocrinol Metab 1998; 83(8): 2635-42.<br />

Rushforth NB, Bennett PH, Steinberg AG et al. Comparison of the value of the two- and one-hour glucose levels<br />

of the oral GTT in the diagnosis of diabetes in Pima Indians. Diabetes 1975; 24(6): 538-46.<br />

Russell-Jones D, Vaag A, Schmitz O et al. LEAD-5 (Met+SU) Study Group. Liraglutide vs insulin glargine and<br />

placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5<br />

met+SU): a randomised controlled trial. Diabetologia 2009; 52(10): 2046-55.<br />

Sacco M, Pellegrini F, Roncaglioni MC et al. Primary prevention of cardiovascular events with low-dose aspirin<br />

and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes<br />

Care 2003; 26(12): 3264-72.<br />

Sadur CN, Moline N, Costa M et al. Diabetes management in a health maintenance organization. Efficacy of care<br />

management using cluster visits. Diabetes Care 1999; 22(12): 2011-7.<br />

Salpeter SR, Buckley NS, Kahn JA et al. Meta-analysis: metformin treatment in persons at risk for diabetes<br />

mellitus. Am J Med 2008; 121(2): 149-57 e2.<br />

Sarol JN, Jr., Nicodemus NA, Jr., Tan KM et al. Self-monitoring of blood glucose as part of a multi-component<br />

therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966-2004). Curr Med Res<br />

Opin 2005; 21(2): 173-84.<br />

Savage S, Estacio RO, Jeffers B et al. Increased complications in noninsulin-dependent diabetic patients treated<br />

with insulin versus oral hypoglycemic agents: a population study. Proc Assoc Am Physicians 1997; 109(2):<br />

181-9.<br />

Scain SF, Friedman R, Gross JL. A structured educational program improves metabolic control in patients with<br />

type 2 diabetes: a randomized controlled trial. Diabetes Educ 2009; 35(4): 603-11.<br />

Scheen AJ. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of<br />

randomised clinical trials. Diabetes Metab 2004; 30(6): 487-96.<br />

Schnipper JL, Barsky EE, Shaykevich S et al. Inpatient management of diabetes and hyperglycemia among general<br />

medicine patients at a large teaching hospital. J Hosp Med 2006; 1(3): 145-50.<br />

Scott JC, Conner DA, Venohr I et al. Effectiveness of a group outpatient visit model for chronically ill older health<br />

maintenance organization members: a 2-year randomized trial of the cooperative health care clinic. J Am<br />

Geriatr Soc 2004; 52(9): 1463-70.<br />

Scott R, Loeys T, Davies MJ et al. Efficacy and safety of sitagliptin when added to ongoing metformin therapy in<br />

patients with type 2 diabetes. Diabetes Obes Metab 2008; 10(10): 959-69.<br />

Appendices Page 143

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!